|
ABY
|
Acta Botanica Yunnanica (Yunnan Zhiwu Yanjiu)
|
|
APS
|
Acta Pharmaceutica Sinica (Yaoxue Xuebao)
|
|
APS
|
Acta Pharmaceutica Sinica (Yaoxue Xuebao)
|
|
c
|
concentration
|
|
c
|
concentration
|
|
CCMM
|
China Journal of Chinese Materia Medica (Zhongguo Zhongyao Zazhi)
|
|
CCMM
|
China Journal of Chinese Materia Medica (Zhongguo Zhongyao Zazhi)
|
|
CTHD
|
Chinese Traditional and Herbal Drugs (Zhongcaoyao)
|
|
CTHD
|
Chinese Traditional and Herbal Drugs (Zhongcaoyao)
|
|
JNP
|
Journal of Natural Product
|
|
JNP
|
Journal of Natural Products
|
|
NPRD
|
Natural Product R&D (Tianran Chanwu Yanjiu Yu Kaifa)
|
|
NPRD
|
Natural Product R&D (Tianran Chanwu Yanjiu Yu Kaifa)
|
|
ZYZ
|
Chinese Pharmaceutical Journal (Zhongguo Yaoxue Zazhi)
|
|
ZYZ
|
Chinese Pharmaceutical Journal (Zhongguo Yaoxue Zazhi)
|
|
5-HT
|
5-hydroxytryptamine
|
|
5-HT
|
5-hydroxytryptamine
|
|
9KB
|
9KB nasopharyngeal carcinoma cell
|
|
9KB
|
9KB nasopharyngeal carcinoma cell
|
|
9PS
|
9PS rat lymphocyte leukaemia cell
|
|
9PS
|
9PS rat lymphocyte leukemia cell
|
|
A-549
|
A-549 human lung cancer cell
|
|
A-549
|
A-549 human lung cancer cell
|
|
ABY
|
Acta Botanica Yunnanica (Yunnan Zhiwu Yanjiu)
|
|
ACTH
|
adrenocorticotropic hormone
|
|
ACTH
|
adrenocorticotropic hormone
|
|
AD
|
Alzheimer’s disease
|
|
AD
|
Alzheimer’s disease
|
|
ADP
|
adenosine diphosphate
|
|
ADP
|
adenosine diphosphate
|
|
AIDS
|
acquired immunodeficiency syndrome
|
|
AIDS
|
acquired immunodeficaency syndrome
|
|
AMP
|
adenosine monophosphate
|
|
AMP
|
adenosine monophosphate
|
|
AMV
|
avian myeloblastosis virus
|
|
AMV
|
avian myeloblastosis virus
|
|
AP
|
angina pectoris
|
|
AP
|
angina pectoris
|
|
ATPase
|
adenosine triphosphatase
|
|
ATPase
|
adenosine triphosphatase
|
|
B16
|
B16 melanoma cell
|
|
B16
|
B16 melanoma cell
|
|
BBB
|
blood-brain barrier
|
|
BBB
|
blood brain barrier
|
|
BHA
|
butylhydroxylanisole
|
|
BHA
|
butylhydroxylanisole
|
|
BST
|
sea shrimp test for cytotoxicity
|
|
BST
|
sea shrimp test for cytotoxic
|
|
cAMP
|
cyclic adenosine monophosphate
|
|
cAMP
|
cyclic adenosine monophosphate
|
|
CD
|
concentration with diploid quinone reductase activity
|
|
CD
|
concentration with diploid quinone reductase activity
|
|
CD50
|
median convulsion dosage
|
|
CD50
|
median convulsion dosage
|
|
cGMP
|
cyclic guanosine monophosphate
|
|
cGMP
|
cyclic guanosine monophosphate
|
|
CIC
|
complete inhibiting concentration
|
|
CIC
|
complete inhibiting concentration
|
|
CIMC
|
complete inhibiting minimum concentration
|
|
CIMC
|
complete inhibiting minimum concentration
|
|
CNS
|
central nervous system
|
|
CNS
|
central nervous system
|
|
ConA
|
concanavalin A
|
|
ConA
|
concanavalin A
|
|
CRF
|
corticotropin releasing factor
|
|
CRF
|
corticotropin releasing factor
|
|
CVS
|
cardiac vascular system
|
|
CVS
|
cardiac vascular system
|
|
d
|
day
|
|
d
|
day
|
|
DMBA
|
dimethylbenzanthracene
|
|
DMBA
|
dimethylbenzanthracene
|
|
DNA
|
deoxyribonucleic acid
|
|
DNA
|
deoxyribonucleic acid
|
|
DPPH
|
1,1-diphenyl-2-m-picrylhydrazyl, free radical
|
|
DPPH
|
1,1-diphenyl-2-m-picrylhydrazyl, free radical
|
|
EA
|
early antigen
|
|
EA
|
early antigen
|
|
EAC
|
Ehrlich ascites cancer
|
|
EAC
|
Ehrlich ascites cancer
|
|
EBV
|
Epstein-Barr virus
|
|
EBV
|
Epstein-Barr virus
|
|
EBV-EA
|
early antigen of Epstein-Barr virus
|
|
EBV-EA
|
early antigen of Epstein-Barr virus
|
|
EC
|
effetive concentration
|
|
EC
|
effective concentration
|
|
ED
|
effetive dosage
|
|
ED
|
effective dosage
|
|
ED25
|
quarter effective dosage
|
|
ED25
|
quarter effective dosage
|
|
ED50
|
median effective dosage
|
|
ED50
|
median effective dosage
|
|
G6PD
|
glucose-6-phosphate dehydrogenase
|
|
G6PD
|
Glucose-6-phosphate dehydrogenase
|
|
GABA
|
gamma aminobutyric acid
|
|
GABA
|
?-aminobutyric acid
|
|
GalN
|
galactosamine
|
|
GalN
|
galactosamine
|
|
GI50
|
median growth inhibition concentration
|
|
GI50
|
median growth inhibition concentration
|
|
GOT
|
glutamate oxaloacetate transaminase
|
|
GOT
|
glutamate-oxaloacetate transaminase
|
|
gpg
|
Guinea pig
|
|
gpg
|
Guinea pig
|
|
GPT
|
glutamate-pyruvate transaminase
|
|
GPT
|
glutamate-pyruvate transaminase
|
|
GTP
|
guanosine triphosphate
|
|
GTP
|
guanosine triphosphate
|
|
GVHR
|
graft-versus-host reaction
|
|
GVHR
|
graft-versus-host reaction
|
|
h
|
hour
|
|
h
|
hour
|
|
HC50
|
median hemolytic concentration
|
|
HC50
|
median hemolytic concentration
|
|
HCT-15
|
HCT-15 human colon cancer cell strain
|
|
HCT-15
|
HCT-15 human colon cancer cell strain
|
|
HeLa
|
cultural cell line from Henrietta Lack (since 1953)
|
|
HeLa
|
cultural cell line from Henrietta Lack (since 1953)
|
|
HEPG-2
|
HEPG-2 human hepatoma cell
|
|
HEPG-2
|
HEPG-2 human hepatoma cell
|
|
HER
|
hypertensive essential rats
|
|
HER
|
hypertensive essential rats
|
|
HIV
|
human immunodeficiency virus
|
|
HIV
|
human immunodeficiency virus
|
|
HIV-RT
|
reverse transcriptase of human immunodeficiency virus
|
|
HIV-RT
|
reverse transcriptase of human immunodeficiency virus
|
|
HL-60
|
HL-60 leukemia cell
|
|
HL-60
|
HL-60 leukaemia cell
|
|
hmn
|
human
|
|
hmn
|
human
|
|
HSV-1
|
herpes simplex virus 1
|
|
HSV-1
|
herpes simplex virus 1
|
|
HT
|
HT sarcoma cell
|
|
HT
|
HT sarcoma cell
|
|
HVA
|
homovanillic acid
|
|
HVA
|
homovanillic acid
|
|
ia
|
intraarterial injection
|
|
ia
|
intra-arterial injection
|
|
IAA
|
indole-3-acetate acid
|
|
IAA
|
indole 3-acetate acid
|
|
IC
|
inhibitory concentration
|
|
IC
|
inhibiting concentration
|
|
IC100
|
all inhibitory concentration
|
|
IC100
|
all inhibiting concentration
|
|
IC50
|
median inhibiting concentration
|
|
IC50
|
median inhibitory concentration
|
|
ID
|
inhibitory dosage
|
|
ID
|
inhibiting dosage
|
|
ID50
|
median inhibitory dosage
|
|
ID50
|
median inhibiting dosage
|
|
im
|
intramuscular injection
|
|
im
|
intramuscular injection
|
|
ip
|
intraperitoneal injection
|
|
ip
|
intraperitoneal injection
|
|
iv
|
intravenous injection
|
|
iv
|
intravenous injection
|
|
KB
|
KB human nasopharyngeal carcinoma culture cells (since 1954)
|
|
KB
|
KB human nasopharyngeal carcinoma cultural cells (since 1954)
|
|
Kichita
|
Kichita sarcoma
|
|
Kichita
|
Kichita sarcoma
|
|
L1210
|
L1210 lymphocyte leukaemia cell strain
|
|
L1210
|
L1210 lymphocyte leukemia cell strain
|
|
L615
|
L615 rat splenic leukaemia cell
|
|
L615
|
L615 rat splenic leukemia cell
|
|
L5178Y
|
L5178Y rat lymphosarcomatosis cell
|
|
L5178Y
|
L5178Y rat lymphosarcomatosis cell
|
|
LC50
|
median lethal concentration
|
|
LC50
|
median lethal concentration
|
|
LD
|
lethal dosage
|
|
LD
|
lethal dosage
|
|
LD100
|
all lethal dosage
|
|
LD100
|
all lethal dosage
|
|
LD50
|
median lethal dosage
|
|
LD50
|
median lethal dosage
|
|
LDH
|
lactate dehydrogenase
|
|
LDH
|
lactate dehydrogenase
|
|
LDL
|
low density lipoprotein
|
|
LDL
|
low density lipoprotein
|
|
LMTK
|
LMTK rat fiber cell
|
|
LMTK
|
LMTK rat fiber cell
|
|
LNCaP
|
LNCaP human prostate oncocyte
|
|
LNCaP
|
LNCaP human prostate oncocyte
|
|
LPS
|
lipopolysaccharide
|
|
LPS
|
lipopolysaccharide
|
|
LTC4
|
leukotriene C4
|
|
LTC4
|
leukotriene C4
|
|
MCF-7
|
MCF-7 human thymocyte
|
|
MCF-7
|
MCF-7 human thymocyte
|
|
MDA
|
methylenedioxyamphetamine
|
|
MDA
|
methylenedioxyamphetamine
|
|
MED
|
minimum effective dosage
|
|
MED
|
minimum effective dosage
|
|
MIC
|
minimum (effective) inhibitory concentration
|
|
MIC
|
minimum (effective) inhibiting concentration
|
|
min
|
minute
|
|
min
|
minute
|
|
MLC
|
minimum lethal concentration
|
|
MLC
|
minimum lethal concentration
|
|
MLD
|
minimum lethal dosage
|
|
MLD
|
minimum lethal dosage
|
|
Molt4
|
Molt4 human leucoma cell
|
|
Molt4
|
Molt4 human leucoma cell
|
|
MQc80-3
|
MQc80-3 adenocarcinoma cell of stomach
|
|
MQc80-3
|
MQc80-3 adenocarcinoma cell of stomach
|
|
MS301
|
MS301 rat breast cancer cell
|
|
MS301
|
MS301 rat breast cancer cell
|
|
MS310
|
MS310 rat breast cancer cell
|
|
MS310
|
MS310 rat breast cancer cell
|
|
MTC
|
minimum toxicity concentration
|
|
MTC
|
minimum toxic concentration
|
|
mus
|
mouse
|
|
mus
|
mouse
|
|
NADH
|
reduced nicotinamide adenine dinucleotide (reduced coenzyme I)
|
|
NADH
|
reduced nicotinamide adenine dinucleotide (reduced coenzyme I)
|
|
NADPH
|
cytochrome C reductase
|
|
NADPH
|
cytochrome C reductase
|
|
NCI
|
National Cancer Institute
|
|
NCI
|
National Cancer Institute
|
|
NGF
|
nerve growth factor
|
|
NGF
|
nerve growth factor
|
|
non-orl
|
non-oral administration
|
|
non-orl
|
non-oral administration
|
|
orl
|
oral administration
|
|
orl
|
oral administration
|
|
P388
|
P388 leukemia lymphocyte
|
|
P388
|
P388 leukaemia lymphocyte
|
|
P1534
|
P1534 rat transplant leukaemia cell
|
|
P1534
|
P1534 rat transplant leukemia cell
|
|
P450
|
cytochrome P450
|
|
P450
|
cytochrome P450
|
|
PAF
|
platelet activating factor
|
|
PAF
|
platelet-activating factor
|
|
PD
|
an exp. model for cytotoxic test
|
|
PD
|
an experimental model for cytotoxicity testing
|
|
PGD2
|
prostaglandin D2
|
|
PGD2
|
prostaglandin D2
|
|
PGE2
|
prostaglandin E2
|
|
PGE2
|
prostaglandin E2
|
|
PGF2alpha
|
prostaglandin F2alpha
|
|
PGF2alpha
|
prostaglandin F2alpha
|
|
PGI2
|
prostacyclin
|
|
PGI2
|
prostacyclin
|
|
PHA
|
plant agglutinin
|
|
PHA
|
plant agglutinin
|
|
pNPPase
|
p-nitrophenylphosphate enzyme
|
|
pNPPase
|
p nitrophenylphosphate enzyme
|
|
q.v.
|
quod vide (see)
|
|
q.v.
|
quod vide (see)
|
|
rbt
|
rabbit
|
|
rbt
|
rabbit
|
|
RI[20, D]
|
optical rotation index at 20°C
|
|
RI[20, D]
|
optical rotation index at 20(C
|
|
RL-33
|
RL-33 rabbit lung cancer cell
|
|
RL-33
|
RL-33 rabbit lung cancer cell
|
|
RM
|
relative mobility
|
|
RM
|
relative mobility
|
|
RNA
|
ribonucleic acid
|
|
RNA
|
ribonucleic acid
|
|
S180
|
sarcoma S180
|
|
S180
|
sarcoma S180
|
|
S37
|
S37 rat liver cancer cell
|
|
S37
|
S37 rat liver cancer cell
|
|
sc
|
subcutaneous injection
|
|
sc
|
subcutaneous injection
|
|
Sca-7901
|
Sca-7901 human adenocarcinoma cell of stomach
|
|
Sca-7901
|
Sca-7901 human adenocarcinoma stomach cell
|
|
SGOT
|
serum glutamate oxaloacetate transaminase
|
|
SGOT
|
serum glutamate-oxaloacetate transaminase
|
|
SGPT
|
serum glutamate-pyruvate transaminase
|
|
SGPT
|
serum glutamate pyruvate transaminase
|
|
SHR
|
spontaneous hypertensive rats
|
|
SHR
|
spontaneous hypertensive rats
|
|
SIZ
|
sulfonamide isoxazole
|
|
SIZ
|
sulfonamide isoxazole
|
|
SK-MEL-2
|
SK-MEL-2 human skin cancer cell strain
|
|
SK-MEL-2
|
SK-MEL-2 human skin cancer cell strain
|
|
SK-OV-3
|
SK-OV-3 human ovarian cancer cell strain
|
|
SK-OV-3
|
SK-OV-3 human ovarian cancer cell strain
|
|
SMMC-7721
|
SMMC-7721liver cancer cell
|
|
SMMC-7721
|
SMMC-7721 liver cancer cell
|
|
sp.
|
species
|
|
sp.
|
species
|
|
spp.
|
more than one species
|
|
spp.
|
multiple species
|
|
SRSA
|
slow reacting substance of anaphylaxis
|
|
SRSA
|
slow reacting anaphylactic substance
|
|
Syn.
|
synonym
|
|
Syn.
|
synonym
|
|
T/C
|
ratio (treated/control) of survival time
|
|
T/C
|
ratio of survival time
|
|
TCM
|
traditional Chinese medicine
|
|
TCM
|
traditional Chinese medicine
|
|
TPA
|
tissue plasminogen activator
|
|
TPA
|
tissue plasminogen activator
|
|
U14
|
U14 rat cervix cancer cell
|
|
U14
|
U14 rat cervix cancer cell
|
|
Vero
|
African green monkey renal fibroblast
|
|
Vero
|
African green monkey renal fibroblast
|
|
VSV
|
vesicular stomatitis virus
|
|
VSV
|
vesicular stomatitis virus
|
|
W256
|
Walker carcinoma 256
|
|
W256
|
Walker carcinoma 256
|
|
XF498
|
XF498 human CNS cancer cell
|
|
XF498
|
XF498 human CNS cancer cell
|
|
X-XOD
|
Xanthine-xanthine oxidase
|
|
X-XOD
|
xanthine-xanthine oxidase
|
